PIVET data demonstrating the influence of cigarette smoking on IVF outcomes
Since cigarette smoking appears to have a detrimental effect on fertility, it is reasonable to assume that cigarette smoking may affect the risk or requirement for IVF. Furthermore, it is entirely possible that female smoking during IVF treatment may adversely affect the subsequent IVF outcomes. Cigarette smoking is the most sufficiently researched lifestyle factor that could affect IVF outcomes, compared to nutrient intake and alcohol consumption. However, the literature is still very limited. Original unpublished data from our laboratory examined the effects of cigarette smoking on oocyte production, fertilization rates, pregnancy and pregnancy loss rates. Lifestyle data collected from these patients is presented in Table
1. The mean number of oocytes retrieved from women undergoing IVF treatment did not significantly differ between regular smokers (11.1 oocytes retrieved, SD 6.5), ex-smokers (11.8, SD 10.1) or non-smokers (11.2, SD 7.6) which indicated that smoking did not influence oocyte production.
Table 1
Overview of lifestyle factors by gender
Female |
smoking (years) | Ex-smokers | 93 | 0.5 | 25.0 | 8.7 | 6.4 | 7.0 | 10.0 |
Occasional smokers | 11 | 5.0 | 29.0 | 12.8 | 6.6 | 10.0 | 5.0 |
Regular smokers | 40 | 6.0 | 25.0 | 15.0 | 5.7 | 15.0 | 10.0 |
Never smokers | 142 | - | - | - | - | - | - |
Nicotine (mg/wk) | Occasional smokers | 11 | 0 | 3.6 | 1.4 | 1.3 | 1.6 | 2.7 |
Regular smokers | 40 | 0.8 | 175.0 | 43.5 | 40.9 | 31.4 | 44.6 |
Alcohol (std drinks/wk) | 286 | 0 | 30.0 | 3.1 | 5.2 | 0 | 4.5 |
F&V (serves/wk) | 286 | 0 | 67.0 | 24.9 | 11.6 | 24.0 | 14.8 |
Male |
Smoke (years) | Ex-smokers | 67 | 0.5 | 30.0 | 9.9 | 6.7 | 10.0 | 9.0 |
Occasional smokers | 11 | 5.0 | 25.0 | 12.8 | 6.0 | 11.5 | 5.8 |
Regular smokers | 51 | 0.5 | 30.0 | 17.4 | 6.7 | 18.0 | 10.0 |
Never smokers | 124 | - | - | - | - | - | - |
Nicotine (mg/wk) | Occasional smokers | 11 | 0 | 4.1 | 1.2 | 1.8 | 0 | 3.6 |
Regular smokers | 51 | 4.9 | 245.0 | 70.7 | 55.1 | 59.8 | 69.6 |
Alcohol (std drinks/wk) | 253 | 0 | 79.0 | 9.9 | 11.6 | 6.5 | 14.0 |
F&V (serves/wk) | 247 | 0 | 54.0 | 21.0 | 10.6 | 20.0 | 14.5 |
As a mechanism to determine the influence of smoking status on ovarian reserve and as a consequence of the age of the presented data, we utilised basal FSH level as an accepted marker of ovarian reserve rather than AMH in smoking and non-smoking women [
18]. It was found that oocyte production lowered along with increased basal FSH levels (
p < 0.001), and basal FSH appeared to increase in tandem with years of cigarette smoking (β = 0.007,
p = 0.035), even after adjusting for the effects of age and infertility status. These results suggested a negative relationship was apparent between years of cigarette smoking and oocyte production, although this was not represented in the mean number of oocytes collected between the smoking status groups. However, we speculate that this observation could be related to the rFSH dosage administered during stimulation before oocyte retrieval, which may compensate for any negative effects of cigarette smoke on oocyte production and ovarian function. Interestingly, the results from our laboratory also showed that fertilization rates were not influenced by current female smoking status (Table
2). However, fertilization rates did decrease as female years of smoking increased (
p < 0.001), and there is an observable and significant interaction between fertilization rates and nicotine (Table
2).
Table 2
Multiple logistic regression analysis of in vitro fertilisation ratesa,b,c (n = 152)
Constant | 0.277 | 0.214 | 0.196 |
Female nicotine (mg/wk) | −0.012 | 0.009 | 0.176 |
Female smoke (years) | −0.047 | 0.010 | < 0.001 |
Female smoke years*nicotine | 0.001 | < 0.001 | 0.044 |
Male alcohol (std drinks/wk) | 0.074 | 0.014 | < 0.001 |
Male F&V (serves/wk) | 0.034 | 0.007 | < 0.001 |
Male alcohol*F&V | −0.001 | 0.001 | 0.011 |
In relation to male patients and applying multiple logistic regression analysis, data from our laboratory showed that male nicotine intake was significantly and positively associated with a first-trimester (up to 12-week) non-ectopic pregnancy loss (
p = 0.008) (Table
3). The risk of pregnancy loss increased by 2.9 % with every 1 mg of nicotine intake in males and after adjusting for female age, the odds ratio (OR) of a first-trimester pregnancy loss for male smokers was 2.2 (95 % CI 1.1–4.3) when compared to non-smokers (Table
3). We speculate that this association between male smoking and pregnancy loss is likely due to the result of spermatozoal DNA damage that occurred pre-conception. However, this was contradictory to female smoking status, where there was no significant effect on pregnancy loss (Table
3).
Table 3
Multiple logistic regression analysis of non-ectopic first trimester pregnancy lossa,b,c (n = 68)
Constant | −12.116 | - | - | < 0.001 |
Female age (years) | 0.311 | 1.365 | (1.139, 1.636) | < 0.001 |
Male nicotine (mg/wk) | 0.024 | 1.024 | (1.006, 1.042) | 0.008 |
Review of data from the literature demonstrating the impact of cigarette smoking on IVF outcomes
Our original research has demonstrated that cigarette smoking influenced several aspects of fertility and female smoking was associated with increased basal FSH and decreased oocyte fertilization, while male smoking was positively correlated with first-trimester pregnancy loss. A range of other studies have been performed that corroborate some of our findings, while others illustrate the complex interplay between lifestyle factors and positive ART outcomes.
It has been demonstrated that actively smoking women had significantly lower serum AMH, when compared to non-smoking women undergoing to IVF, which indicated a negative impact on ovarian reserve [
14]. In addition, it was reported that smoking couples had a reduction in the number of oocytes retrieved (by 40 %), while those with smoking male partners were reduced by a further 5 % [
19]. However, other researchers have found that the mean number of oocytes retrieved for smokers (9.6 oocytes) and non-smokers (9.0 oocytes) was not significantly different [
20]. Taken together, these outcomes echo those presented in our study above where female smoking was associated with increased basal FSH, but this did not manifest in significant differences in the number of oocytes collected or pregnancy loss rates. Consequently, this observation may be related to rFSH stimulation regimens, where some clinics apply a standard dosage based on female age, while others, including PIVET, applied a step-up dosage for those women not responding optimally [
21].
Interestingly, a study conducted in Dutch IVF clinics examined the effect of smoking on the IVF success rate in 8457 women [
20], and they showed that smoking decreased the live birth rate by 7.3 %. Furthermore, the spontaneous abortion rate per pregnancy was higher for smokers at 21.4 % compared with 16.4 % for non-smokers [
20]. We observed that female smoking years and nicotine intake was not associated with first-trimester pregnancy loss, but the difference between the studies may be first explained in a practical sense by the larger sample size in the Dutch study [
20]. Second, there is also the clear possibility that smoking women in our smaller cohort, who have become pregnant following IVF, would alter and probably cease their smoking habits upon being informed of successful pregnancy. It is therefore not astonishing that female smoking status does not have a significant impact on most IVF outcomes in our study as it is likely they will modify their behaviour. However, in other work, the risk ratio (RR) for smoking couples failing to become pregnant was doubled when compared to non-smoking couples [
19]. Moreover, the RR increased by 4 % for each additional year of smoking. In addition, the authors reported that live birth rates were significantly decreased for smoking couples in comparison to non-smoking couples [
19]. They also demonstrated that if a woman had smoked during her lifetime, she was twice as likely to fail becoming pregnant compared to non-smoking women. This risk eventually increased by 9 % with each additional year of smoking.
A meta-analysis conducted in 2008 included 21 studies that focused on reproductive outcomes and lifestyle factors [
22]. They found that cigarette smokers had a significantly lower pregnancy and live birth rates per cycle in comparison with non-smokers. In the same meta-analysis, smoking was also significantly associated with an increased risk of spontaneous miscarriage. However, there was no association between smoking and fertilization rates in 17 studies that included fertilization rate parameters [
22]. Conversely, Zitzmann et al. [
23] reported that fertilization rates in IVF patients were influenced by female smoking. Importantly, in addition to active smoking status, an association between passive smoking and IVF outcome has also been shown to impair fertility parameters [
24]. In one study, patients who were exposed to side stream smoke had lower pregnancy rates that were equal to mainstream smokers [
24]. Since other studies have shown that increased levels of reactive oxygen species (ROS) in follicular fluid were correlated with poor oocyte quality [
25], there remains the possibility that the decrease in oocyte production may be due to the increased levels of ROS promoted by cigarette smoking over a long period of time. The involvement of ROS in male and female fertility is described in more detail later in the present manuscript. However, despite several laudable studies investigating the effect of female smoking on IVF outcomes, the research is still very limited and much more work is required.
Comparably, the effect of male smoking alone on IVF outcomes is another area that is lacking. It has been indicated that for couples undergoing IVF (
n = 148) and ICSI (
n = 153), a woman with a smoking male partner had lower ICSI success rates (22 %), compared to 8 % for women with non-smoking partners [
23]. Furthermore, the authors found similar results for IVF, where IVF success rate was 18 % for women with smoking partners and 32 % with non-smoking partners in 213 treatment cycles. Recent reports have suggested that smoking negatively affects semen quality parameters including morphology [
26,
27] and motility [
27], yet the biological mechanism remains unclear. However, one of the main constituents of cigarette smoke is the highly mutagenic and carcinogenic compound benzo[a]pyrene [
28]. Research has found that sperm exposed to benzo[a]pyrene display a moderately increased amount of DNA fragmentation, along with increased benzo[a]pyrene adducts on DNA in comparison with non-exposed sperm [
29]. Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF [
30], therefore exposure to benzo[a]pyrene and the resulting DNA damage could be a potential mechanism leading to increased risk for pregnancy loss with male smoking partners. Taken together, all of these results, including the previously unpublished results from our laboratory, imply that for women undergoing IVF treatment with a partner who smokes cigarettes, there may be a negative impact on the subsequent IVF outcome. Consequently, couples undergoing IVF treatment should consider the cessation of smoking to enhance likelihood of a successful IVF outcome.